Clinical Trial Update: A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports a de-escalating strategy for antibiotic treatment of pneumonia in the medical intensive care unit. The study with Merck Sharp &…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infection, Pneumonia | Phase 4 | Status: COMPLETED